Laura E. Dichtel

机构：Massachusetts General Hospital, Rapt Therapeutics (United States) · ORCID：0000-0001-6989-2308

发表论文 78 篇 · 总被引 2816 次 · h-index 26

代表论文

• Clonal haematopoiesis and risk of chronic liver disease (2023 · Nature · 被引 208)
• Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis (2024 · JAMA · 被引 88)
• Growth Hormone Administration Improves Nonalcoholic Fatty Liver Disease in Overweight/Obesity: A Randomized Trial (2023 · The Journal of Clinical Endocrinology & Metabolism · 被引 32)
• Real‐World Assessment of Liver Corrected T1 and Magnetic Resonance Elastography in Predicting Liver Disease Progression (2025 · Liver International · 被引 16)
• Higher serum myostatin levels are associated with lower insulin sensitivity in adults with overweight/obesity (2024 · Physiological Reports · 被引 8)
• CT Texture Analysis in Nonalcoholic Fatty Liver Disease (NAFLD) (2023 · Journal of Clinical and Experimental Hepatology · 被引 8)